ALC

Alcon Inc. is the global leader in eye care, developing and manufacturing products for the treatment of eye diseases and vision correction. The company operates through Surgical (equipment and consumables for cataract and refractive surgery, vitreoretinal surgery) and Vision Care (contact lenses and contact lens care products) segments. Alcon's surgical portfolio includes intraocular lenses, ophthalmic surgical equipment, surgical instruments, and pharmaceuticals used in eye surgery. The Vision Care segment produces contact lenses under brands including Dailies, Air Optix, and Precision1, along with solutions for lens care. Alcon serves ophthalmologists, optometrists, hospitals, retail optical chains, and consumers worldwide through a global commercial organization. The company invests in innovation across surgical technologies, premium intraocular lenses, and next-generation contact lenses. Alcon was spun off from Novartis in 2019 to create a pure-play eye care business. Headquartered in Geneva, Switzerland, with U.S. operations in Fort Worth, Texas, Alcon benefits from aging populations, increasing cataract surgeries, myopia prevalence, and premiumization trends in vision correction.